Figure 2From: The proinsulin/insulin (PI/I) ratio is reduced by postprandial targeting therapy in type 2 diabetes mellitus: a small-scale clinical studyIRI response in meal tolerance test. Peak IRI shifted from 120 to 30 min by mitiglinide treatment (a). The pattern of insulin secretion was not changed by glimepiride treatment (b).Back to article page